AI assistant
DEVRO PLC Earnings Release 2022
4717_er_2023-01-20_c983389c-0bbe-4799-b134-e9d0610b8a17.html
Earnings Release
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 3312N
Devro PLC
20 January 2023
Devro plc
Full Year Trading Update
Devro plc ("Devro" or the "Group"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period 1 January to 31 December 2022 ("period").
Current trading
The Group traded well throughout the period with reported revenue of circa £290m reflecting growth of around 15% (11% at constant currency) compared to 2021. Constant currency revenue growth was driven by higher pricing, reflecting successful recovery of cost inflation, as well as good volume increases particularly in our mature markets.
The second half of the year delivered strong operating margins, reflecting the benefits of management's pricing actions, operating efficiency and foreign exchange tailwinds.
As a result, adjusted operating profit is anticipated to be ahead of the Board's expectations, subject to any audit adjustments.
Financial position
Cash generation in the period remained robust, despite higher working capital and capital expenditure to facilitate further growth, with Group covenant net debt of around £90m at year end.
ENDS
Contacts:
Devro plc
| Chris Dyett | Tel : 07974 974 690 |
| Investor Relations |
FTI Consulting
| Richard Mountain | Tel: 07909 684 466 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTSFSESUEDSEFF